The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Metal ions, Alzheimer's disease and chelation therapy
Open accessAbstract
Metal ions, Alzheimer's disease and chelation therapy: In the last few years, various studies have been providing evidence that metal ions are critically involved in the pathogenesis of major neurological diseases (Alzheimer, Parkinson). Metal ion chelators have been suggested as potential therapies for diseases involving metal ion imbalance. Neurodegeneration is an excellent target for exploiting the metal chelator approach to therapeutics. In contrast to the direct chelation approach in metal ion overload disorders, in neurodegeneration the goal seems to be a better and subtle modulation of metal ion homeostasis, aimed at restoring ionic balance. Thus, moderate chelators able to coordinate deleterious metals without disturbing metal homeostasis are needed. To date, several chelating agents have been investigated for their potential to treat neurodegeneration, and a series of 8-hydroxyquinoline analogues showed the greatest potential for the treatment of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is known to transfer metal ions from extracellular environment to intra cellular environment of the cell to maintain metal ion balance and also dissolves Ab-Cu2+/Zn2+aggregates [125, 126].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [125]
Experimental — accuracy not yet measuredIn the citing paper
“Clioquinol from class 8-hydroxyquinoline has shown better results in treating neurodegenerative disease.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [125]
In the citing paper
“Interaction of metals with Aβ leads to the generation of ROS as well as abnormal metal ion homeostasis which is linked to the pathogenesis of AD.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [125]
In the citing paper
“It is a bi-dentate ligand which has 2:1 activity against copper and zinc ions.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [125]
In the citing paper
“Metal chelators are agents that break the Aβ-metal complex and restore metal ion homeostasis and hence reduce neuro toxicity.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [125]
In the citing paper
“Consequently, the emergence of CQ as an anti-AD drug has been halted due to potential neurotoxicity and undesirable mutagenic contaminants (Budimir et al., 2011).”
From An update on the novel and approved drugs for Alzheimer disease (2022) · cites this paper as Budimir et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
3D structure of Alzheimer's amyloid-β(1–42) fibrils
Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D. A., & Riek, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506723102 · Cited by 2,001
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Research works printed but not linked: 2
- C. P. Ferri, R. Sousa, E. Albanese, W. S. Ribeiro and M. Honyashiki, World Alzheimer Report 2009 - Executive Summary (Eds. M. Prince and J. Jadeson), Alzheimer's Disease International, London 2009, pp. 1-22; http://www.alz.co.uk/adi/publications.html
- R. Cherny, 1999, Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion, J. Biol. Chem, 274, 23223, 10.1074/jbc.274.33.23223 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 206
Frizzell, N., & Baynes, J. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0881 · Cited by 17
Xu, Z., Lu, H., Lü, J., Lv, C., Zhao, X., & Wang, G. (2018) · RSC Advances · doi:10.1039/c7ra10807a · Cited by 17
Part, K., Künnis-Beres, K., Poska, H., Land, T., Shimmo, R., & Zetterström Fernaeus, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.034 · Cited by 16
Ashraf, M., Hussain, R., Khan, S., Rehman, W. U., Khan, Y., Sardar, A., Aziz, T. A., & Khowdiary, M. M. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.137317 · Cited by 16
Menezes, L. B., Sampaio, R. M. S. N., Meurer, L., Szpoganicz, B., Cervo, R., Cargnelutti, R., Wang, L., Yang, J., Prabhakar, R. S., Fernandes, C., et al. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c00232 · Cited by 16
Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease
Ngoc, A. P. T., Zahoor, A., Kim, D., & Yang, S. H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2403.03021 · Cited by 16
New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations
Fu, C., Hsu, L., Liao, Y., & Hu, M. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500453 · Cited by 16
Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
Singh, S. K., Srikrishna, S., Castellani, R. J., & Perry, G. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-67625-8_20 · Cited by 16
Umar, T., Shalini, S., Raza, M. K., Gusain, S., Kumar, J., Ahmed, W., Tiwari, M., & Hoda, N. (2018) · MedChemComm · doi:10.1039/c8md00312b · Cited by 16
The salen based chemosensors for highly selective recognition of Zn2+ ion
Zhu, W., Du, L., Li, W., Zuo, J., & Shan, J. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.06.008 · Cited by 16
Designing a new multifunctional peptide for metal chelation and Aβ inhibition
Shamloo, A., Asadbegi, M., Khandan, V., & Amanzadi, A. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.06.004 · Cited by 15
Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores
Rangel, M., Moniz, T., Silva, A. M. N., & Leite, A. (2018) · Pharmaceuticals · doi:10.3390/ph11040110 · Cited by 15
Adhikari, A., Biswas, P., Mondal, S., Das, M., Darbar, S., Hameed, A. M., Alharbi, A., Ahmed, S. A., Bhattacharya, S. S., Pal, D., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900543 · Cited by 15
Selenoproteins: Zoom-In to Their Metal-Binding Properties in Neurodegenerative Diseases
Duţă, C., Muscurel, C., Dogaru, C. B., & Stoian, I. A.-M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031305 · Cited by 14
Ren, H., Zhang, Y. A., Guo, S., Lin, N., Deng, L. P., Yue, T., & Huang, F. L. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp06206k · Cited by 14
Cadmium Neurotoxicity and Its Role in Brain Disorders
Leal, R. B., Rieger, D. K., Peres, T. V., Lopes, M. W., & Gonçalves, C. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_34 · Cited by 13
Neuritogenic activity of bi-functional bis-tryptoline triazole
Jiaranaikulwanitch, J., Tadtong, S., Govitrapong, P., Fokin, V. V., & Vajragupta, O. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.027 · Cited by 13
Mir, J. M., Rajak, D. K., & MAURYA, R. C. (2018) · Journal of Coordination Chemistry · doi:10.1080/00958972.2018.1482488 · Cited by 13
Baul, T. S. B., Kundu, S., Singh, P., Shaveta, S., & da Silva, M. F. C. G. (2014) · Dalton Transactions · doi:10.1039/c4dt03151b · Cited by 13
Dienemann, C., Coburger, I., Mehmedbašić, A., Andersen, O. M., & Than, M. E. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00111 · Cited by 12
Physalis minima L. Fruit- A Promising Approach To Alzheimer's Disease
Joseph, L., & Ravi, C. (2021) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100038 · Cited by 12
Memory restorative ability of clioquinol in copper–cholesterol-induced experimental dementia in mice
Mehra, R., Sodhi, R. K., & Aggarwal, N. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.974061 · Cited by 12
Understanding Alzheimer’s Disease and its Metal Chelation Therapeutics: A Narrative Review
Thakur, R., Karwasra, R., & Umar, T. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128263992231012113847 · Cited by 11
Porphyromonas Gingivalis May Seek the Alzheimer’s Disease Brain to Acquire Iron from Its Surplus
Olsen, I. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200272 · Cited by 12
The binding abilities of homodetic cyclic His-peptides toward copper ions
Kotynia, A., Pap, J. S., & Brasuń, J. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.07.028 · Cited by 10
González, M. L., Ramírez‐Apán, M. T., Nieto‐Camacho, A., Toscano, R. A., Sánchez-Sandoval, A. L., & Alvarez, C. T. (2017) · New Journal of Chemistry · doi:10.1039/c7nj04266c · Cited by 10
H4HBEDpa: Octadentate Chelate after A. E. Martell
Choudhary, N., Scheiber, H., Zhang, J., Patrick, B. O., Jaraquemada-Peláez, M. D. G., & Orvig, C. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c01175 · Cited by 10
Drommi, M., Rulmont, C., Esmieu, C., & Hureau, C. (2021) · Molecules · doi:10.3390/molecules26247630 · Cited by 10
Yerdelen, K. Ö., Koca, M., Kasap, Z., & Anıl, B. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.959947 · Cited by 10
Korin, E., Cohen, B., Bai, Y., Zeng, C., & Becker, J. Y. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.06.071 · Cited by 9
Huang, K., Ma, K., Hung, Y., Lo, L., Lin, K., Liu, P., Hu, M., & Chueh, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26861 · Cited by 9
Shamle, N. J., Tella, A. C., Obaleye, J. A., Balogun, F. O., Ashafa, A. O. T., & Ajibade, P. A. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128585 · Cited by 9
Zhang, L., Cao, J., Chen, K., Liu, Y., Ge, Y., Wu, J., & Liu, D. (2019) · New Journal of Chemistry · doi:10.1039/c8nj06552g · Cited by 9
Mao, M., Komes, D., Zhao, S., Pjanović, R., Wang, D., & Wang, Y. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100121 · Cited by 8
Guan, Q., Cao, Y., Zhang, Y., Zhou, B., Wang, J., Baranenko, D., Cifuentes, A., Ibañez, E., Yuan, C., & Lu, W. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105177 · Cited by 9
Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases
Zhang, L., Sun, H., Chen, Y., Wei, M., Lee, J., Li, F., & Ling, D. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1696 · Cited by 8
Synthesis and structural characterization of a 8-hydroxyquinoline derivative coordinated to Zn(II)
Freitas, L. V. D., Santos, A. L. D. S. F. D., Costa, F. C. D., Calixto, J. B., Miranda, P. V. P., Silva, T. J. J., Pereira, E. S., Rocha, W. R., Almeida, W. B. D., Souza, L. A. D., et al. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.05.050 · Cited by 8
Baul, T. S. B., Nongsiej, K., Biswas, K., Joshi, S. R., & Herbert Höpfl, B. (2018) · Inorganica Chimica Acta · doi:10.1016/j.ica.2018.06.049 · Cited by 8
Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases
Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8
Wang, X., Ma, M., Feng, Y., Li, J., & Wang, G. (2025) · Molecules · doi:10.3390/molecules30173489 · Cited by 8
Kurt, A. H., Yüksel, K. Z., Üremiş, N., Üremi̇ş, M. M., Altun, İ., Boşnak, M., Kılıçaslan, D., & Alli, B. (2019) · Neurochemical Journal · doi:10.1134/s1819712419010148 · Cited by 7
Иванова, И. С., Tsebrikova, G. S., Ilyukhin, A. B., Solov’ev, V. P., Лапшина, М. А., Rogacheva, Y. I., Pyatova, E. N., Баулин, В. Е., & Tsivadze, A. Y. (2023) · Russian Journal of Inorganic Chemistry · doi:10.1134/s0036023623601393 · Cited by 7
Koca, M., Yerdelen, K. Ö., Anıl, B., & Kasap, Z. (2015) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c14-00754 · Cited by 7
Flora, S. J. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097774-4.00340-5 · Cited by 7
Tam, J. P., Huang, J., Loo, S., Li, Y.-M., & Kam, A. (2023) · Molecules · doi:10.3390/molecules28186556 · Cited by 6
Евтушок, В. Е., & Vorob’ev, A. Y. (2019) · Chemistry of Heterocyclic Compounds · doi:10.1007/s10593-019-02446-0 · Cited by 6
Ali, S. H., Osmani̇ye, D., & Kaplancıklı, Z. A. (2025) · RSC Advances · doi:10.1039/d5ra05755h · Cited by 5
Calculation of Solubility of Oxyquinolinates
Michałowska‐Kaczmarczyk, A. M., & Michałowski, T. (2014) · Journal of Analytical Sciences Methods and Instrumentation · doi:10.4236/jasmi.2014.43010 · Cited by 5
Asadbegi, M., & Shamloo, A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01264 · Cited by 5
Molecular scaffold and biological activities of anti- Alzheimer agents
Alanazi, F. K., Radwan, A. A., & Aou-Auda, H. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i2.30 · Cited by 5
Peñafiel, M. J. P., Falco, A. D., Miranda‐Andrades, J. R., Almeida, J. M. S., Larrudé, D. G., Rey, N. A., & Aucélio, R. Q. (2020) · Analytical Letters · doi:10.1080/00032719.2020.1741603 · Cited by 5
Copper interaction with cystatin C: effects on protein structure and oligomerization
Żygowska, J., Orlikowska, M., Zhukov, I., Bal, W., & Szymańska, A. (2024) · FEBS Journal · doi:10.1111/febs.17092 · Cited by 5
Kim, H. Y., Kwon, J. A., Kang, T., & Choi, I. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.01.004 · Cited by 5
Chen, L., Hu, Y., Cheng, Y., & Wang, H. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c03275 · Cited by 4
Baul, T. S. B., Chaurasiya, A., Nonglait, B. L., Lyčka, A., Schollmeyer, D., & Jurkschat, K. (2021) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2021.121898 · Cited by 4
Study on Multi-Target Synergistic Treatment of Alzheimer’s Disease Based on Metal Chelators
Shen, R., Kou, X., Yang, A., Wu, J., & Chen, Y. (2022) · Current Drug Targets · doi:10.2174/1389450123666220926143920 · Cited by 4
Synthesis and Characterization of a Zinc(II) Complex of Bispicen
Parajón‐Costa, B. S., Echeverría, G. A., Piro, O. E., & Baran, E. J. (2013) · Zeitschrift für Naturforschung B · doi:10.5560/znb.2013-3193 · Cited by 4
Synthesis of Some Novel Quinolinols with In-vitro Antimicrobial, and Antioxidant Activity
Shehab, M. A., El-Naggar, M. H., Ismail, R. A., Kafrawy, H. M. E., Abood, A., Ismail, S. A., Sabry, N. M., & Sayed, M. T. E. (2019) · Current Bioactive Compounds · doi:10.2174/1573407215666190131112730 · Cited by 4
Iodine, A., Chipiso, K., Duc, T., & Simoyi, R. H. (2018) · South African Journal of Chemistry · doi:10.17159/0379-4350/2019/v72a1 · Cited by 4
Zonzin, M., Chianese, M., Squarcina, A., Dereje, D. M., Campofelice, A., Fermo, A. D., Belluti, F., Marino, N., Dębicki, F., Kotynia, A., et al. (2025) · Molecules · doi:10.3390/molecules30163419 · Cited by 3
Mondal, S., Bayan, S., Ghosh, R., Das, M., Adhikari, A., Mukherjee, D., Mallick, A. K., Ray, S. K., & Pal, S. K. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02377 · Cited by 3
Various pharmacological agents in the pipeline against intractable epilepsy
Waris, A., Asim, M., Ullah, A., & Alhumaydhi, F. A. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400229 · Cited by 3
Korkmaz, I. N., Kalın, R., & Özdemіr, H. (2020) · Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.21597/jist.669441 · Cited by 3
Potansiyel karbonik anhidraz I ve II inhibitör keşfi: D-Penisilamin türevleri
Korkmaz, I. N. (2023) · Gümüşhane Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.17714/gumusfenbil.1359988 · Cited by 2
Application of Organic Complex Compounds as Drug
-, D. K. S., -, B. B. S., -, V. K. S., & -, M. N. A. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i04.24900 · Cited by 2
Sun, B., & Jiang, H. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112636 · Cited by 2
Iduh, M. U., Imam, U. A., Muhammad, N. B., Enitan, S. S., & Hassan, Y. (2024) · International Journal of Pathogen Research · doi:10.9734/ijpr/2024/v13i4300 · Cited by 2
Baryłka, A., Santonoceta, G. D. G., Gattuso, G., Godlewska‐Żyłkiewicz, B., Sgarlata, C., Milea, D., & Gama, S. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126671 · Cited by 2
Robak, W., Apostoluk, W., Maciejewski, P., Pielka, J. A., & Kwiotek, J. N. (2013) · Journal of Chemical & Engineering Data · doi:10.1021/je3009045 · Cited by 2
Metal Ions-Mediated Oxidative Stress in Alzheimer’s Disease and Chelation Therapy
Yeo, D., Choi, T. G., & Kim, S. S. (2021) · Biochemistry · doi:10.5772/intechopen.99690 · Cited by 2
Zhang, Y., You, X., Ren, Y., & Cui, J. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v22i2.30 · Cited by 2
Das, S. (2023) · Asian Journal of Chemistry · doi:10.14233/ajchem.2023.26944 · Cited by 1
Sayar, P., Maral, M., Yildiz, E., & Erdem, A. (2025) · Electroanalysis · doi:10.1002/elan.12049 · Cited by 1
Tolbatov, I., Marzo, T., Peana, M., Medici, S., Zoroddu, M. A., Mendola, D. L., & Marrone, A. (2025) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2025.112979 · Cited by 1
Novel Schiff base-Pt( ii ) complexes: inhibition of Aβ aggregation via histidine interaction
İrişli, S., Doğan, U., Günnaz, S., Yurt, F., & Şahin, O. (2025) · New Journal of Chemistry · doi:10.1039/d5nj04180e · Cited by 1
Zhang, Z., Sun, S. S., Xu, J., Zhang, J., Huang, Y., Zhang, B., & Tao, Y. (2013) · Journal of Physics Conference Series · doi:10.1088/1742-6596/430/1/012041 · Cited by 1
A Missing Origin of the Tau Protein Aggregation Pathway Triggered by Thermal and Biological Forces
Lu, H. P. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206145 · Cited by 1
Shifting Paradigm in Early Detection and Prediction of Alzheimer's Disease
Bashir, T., Akhouri, D., & Hamza, H. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-1090-8.ch013 · Cited by 1
Copper metabolism and copper-mediated alterations in the metabolism of cultured astrocytes
Scheiber, I. F. (2012) · State and University Library Bremen · Cited by 1
Shruthila, N., Narayan, P., Kumar, D. J., & Nagendra, H. G. (2013) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2013.050407 · Cited by 1
Tihile, M. S., & Chaudhari, G. N. (2020) · Journal of Emerging Technologies and Innovative Research · Cited by 1
The role of trace elements in Alzheimer's disease
Purushothaman, S., Ragavi, A., Basavaraju, P., Moorthi, P., & Anand, A. V. (2020) · Archives of Mental Health · doi:10.4103/amh.amh_18_20 · Cited by 1
Guettaf, S., Benmerzoug, A., Bensouıcı, C., Çakmak, Y. S., Dahamna, S., Baghiani, A., & Harzallah, D. (2022) · Current Enzyme Inhibition · doi:10.2174/1573408018666220324101521 · Cited by 1
Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance
Petersingham, G., Zaman, M. S., Johnson, A. J., Reddy, N., Torres, A. M., & Wu, M. J. (2022) · BioMetals · doi:10.1007/s10534-022-00399-0 · Cited by 1
Schmued, L. C., Maloney, B., Schmued, C., & Lahiri, D. K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221285 · Cited by 1
Alzheimer’s Disease Management: Current Therapy and Recent Drug Development
Abbasi, M., & Alam, M. R. (2016) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2016/24771
RĂPUNTEAN, S., Pop, A., Miclăuş, V., Garbo, C., Chirila, F., Răpuntean, G., Nicodim Iosif, F. I. T., Farcau, H., & Tomoaia-Cotişel, M. (2016) · Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine · doi:10.15835/buasvmcn-vm:12203
Wegermann, C. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2018.tde-20072018-093655
The amyloidogenic properties of the CAP superfamily proteins
Sheng, J. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/530
Żamojć, K., Streńska, K., Wyrzykowski, D., Chmurzyński, L., & Makowska, J. (2020) · Symmetry · doi:10.3390/sym12101579
Glutathione As Biomarker for Neurodegenerative Diseases
(2020) · Journal of Bioscience & Biomedical Engineering · doi:10.47485/2693-2504.1020
Gál, G. T. (2022) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2021.154
Иванова, И. С., Tsebrikova, G. S., Ilyukhin, A. B., Solov’ev, V. P., Лапшина, М. А., Rogacheva, Y. I., Pyatova, E. N., Баулин, В. Е., & Tsivadze, A. Y. (2023) · Журнал неорганической химии · doi:10.31857/s0044457x23600597
Liu, W., Bai, Y., Qu, W., Zhang, X., Zhou, S., Luo, H., Zhu, M., Li, D., & Fang, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1752446
Metadata
- Authors
- Budimir, A.
- Affiliations
- University of Zagreb (HR)
- Corresponding author
- Budimir, Ana
- ORCID
- Budimir, Ana
- Venue
- Acta Pharmaceutica
- Publisher
- Walter de Gruyter GmbH
- Published
- 2011-03-01
- Volume
- 61
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1330-0075 (ISSN-L)
- 1846-9558
- OpenAlex
- W2033807567
- Cited by
- 202
- References
- 75
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 13 · 2023: 12 · 2022: 14 · 2021: 18 · 2020: 18 · 2019: 15 · 2018: 19 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 14 · 2013: 12 · 2012: 12
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Acta Pharmaceutica (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Zagreb University Computing Centre (SRCE) (submittedVersion, other-oa)
- Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu) (submittedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- metal ions, Alzheimer's disease, chelation therapy, metal chelators, neurodegeneration, metal homeostasis, Parkinson's disease, metal imbalance
- MeSH terms
- Alzheimer Disease, Animals, Chelating Agents, Homeostasis, Humans, Hydroxyquinolines, Ions, Metals, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review